Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Wednesday, April 13, 2005 | ENZO Biochem to Present at White Mountain Capital Third Annual Biotechnology Conference |
Monday, December 12, 2005 | ENZO Biochem Reports Fiscal 2006 First Quarter Operating Results |
Thursday, December 08, 2005 | Discussion of Fiscal 2006 First Quarter Operating Results |
Friday, November 04, 2005 | ENZO Biochem Appoints Melvin F. Lazar As Lead Independent Director |
Friday, October 14, 2005 | ENZO Biochem Reports Results For Fourth Quarter And Fiscal Year |
Wednesday, October 12, 2005 | ENZO Biochem Announces Conference Call Rescheduled For Monday, October 17th |
Tuesday, October 11, 2005 | ENZO Biochem, Inc. Schedules Fiscal 2005 Fourth Quarter And Year-End Operating Results Teleconference For Friday October 14, 2005, At 8:30 Am E.T. |
Thursday, October 06, 2005 | ENZO Biochem Says Pre-Clinical Study Suggests Small Molecule Compound Could Spur Bone Growth |
Thursday, June 09, 2005 | ENZO Biochem Reports Results for the Fiscal Third Quarter and Nine Months |
Thursday, June 09, 2005 | ENZO Biochem Acquires Rights To Orphan Drug Candidate For Treating Uveitis, Chronic Inflammation Of The Eye |
Tuesday, June 07, 2005 | Discussion of Fiscal 2005 Third Quarter Operating Results |
Wednesday, May 25, 2005 | ENZO Life Sciences Launches New DNA Labeling System For Comparative Genomic Hybridization Microarrays |
Wednesday, May 18, 2005 | ENZO Biochem to Present at Needham & Company Fourth Annual Biotechnology Conference |
Monday, May 16, 2005 | ENZO Biochem Alequel™ Clinical Trial Results Highlighted At Digestive Disease Week Conference Press Meeting Today |
Friday, April 15, 2005 | ENZO Biochem Reports Supporting Laboratory Studies At European Liver Conference |
Friday, April 08, 2005 | ENZO Biochem Unit Allowed Interference Action |
Monday, March 14, 2005 | ENZO Biochem Reports First Half And Fiscal Second Quarter Operating Results |
Tuesday, March 08, 2005 | Discussion of First Half and Fiscal 2005 Second Quarter Operating Results |
Tuesday, January 11, 2005 | ENZO Biochem Awarded $1 Million Grant to Fund Clinical Trial of Liver Disease Treatment |